DataMEDS AI, Inc. (MEDS) |
| 1.03 0.04 (4.04%) 09-02 16:00 |
| Open: | 0.9696 |
| High: | 1.05 |
| Low: | 0.9321 |
| Volume: | 119,624 |
| Market Cap: | 3(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Distribution |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 3.74 |
| Resistance 1: | 2.63 |
| Pivot price: | 1.28 |
| Support 1: | 0.82 |
| Support 2: | 0.68 |
| 52w High: | 86 |
| 52w Low: | 0.823 |
DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRx™ and blockchain-enabled smart contacts platform PharmacyChain™ to optimize the prescription medicines reimbursement and dispensing journey.
| EPS | -48.300 |
| Book Value | -6.880 |
| PEG Ratio | 0.00 |
| Gross Profit | -2.376 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -412.68 |
| Return on Assets (ttm) | -82.9 |
| Return on Equity (ttm) | 0.0 |
Tue, 01 Sep 2026
DataMeds AI Inc. (MEDS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Mon, 31 Aug 2026
MEDS Stock Draws Traders As Corexa Pharmacy Revenue Holds Strong - timothysykes.com
Fri, 28 Aug 2026
DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM) - webull.com
Thu, 27 Aug 2026
DataMeds AI and Tollo Health Announce Fall 2026 Cold & Flu #Back2School50% Marketing Campaign for Viral Infections Medical Food Galectovid(TM) - The Killeen Daily Herald
Thu, 27 Aug 2026
DataMeds AI, Inc. Revenue Breakdown – NASDAQ:MEDS - TradingView
Tue, 18 Aug 2026
DataMeds AI (NASDAQ: MEDS) faces $19.5M deficit, 1-for-50 reverse split - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |